Asclepius 2025

3 papers
The 2025 edition of Asclepius focused on personalized medicine and the management of chronic conditions through technological and pharmacological innovation. Research themes emphasized continuous physiological sensing for early warning systems, genotype stratification for therapeutic selection, and the integration of multimodal data for clinical management. A significant portion of the work addressed the intersection of clinical innovation and economic accessibility, alongside strategies to reduce patient burden in long-term medical therapies. Specific studies examined advancements in treating arterial hypertension, asthma, and depression, highlighting both pharmacological and non-pharmacological approaches. Notable research directions included targeted neuromodulation for neural circuitry enhancement and the use of biomarkers to predict early responses to psychiatric treatment. Contributions from authors such as Aline Benício De Almeida Rochedo, Bianca Rodrigues dos Santos Coelho, and Fellipe Pinheiro Lopes explored computational phenotyping for heterogeneous syndromes and high-precision non-invasive neural interfaces. These works aimed to bypass pharmacological resistance in chronic psychiatric disorders and improve precision in complex clinical management.

Top Research Directions

The 14 research directions with Asclepius 2025 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.

#DirectionPapersShare
1Continuous Physiological Monitoring for Proactive Early Warning266.7%
2Mechanisms of Patient Attrition and Adherence in Long-Term Therapy266.7%
3Biological Subtyping to Parse Clinical Heterogeneity133.3%
4Biopsychosocial Integration for Chronic Disease Management133.3%
5Correcting Ascertainment Bias in Passive Disease Surveillance133.3%
6Multimodal Integration for Synergistic Clinical Outcomes133.3%
7Non-Invasive High-Precision Neuromodulation of Deep Brain Circuits133.3%
8Non-Invasive Modulation of Cortical Excitability and Networks133.3%
9Objective Biomarkers for Neuropsychiatric and Complex Conditions133.3%
10Overcoming the Limitations of Monoaminergic Antidepressants133.3%
11Overcoming the Limitations of Standardized Clinical Protocols133.3%
12Socioeconomic Barriers and the Efficacy Effectiveness Gap133.3%
13Synergistic Multidomain Interventions for Complex Health Conditions133.3%
14Therapeutic Simplification through Regimen Consolidation133.3%

Download all directions as CSV

Institutions

Institutions credited by Asclepius 2025 papers: a paper credits every institution named in its affiliations, once. 7 institutions share 3 credited papers.

#InstitutionPapersShare
1005mpbw70 3100.0%
2009rsan39 3100.0%
300ajzsc28 3100.0%
4044g0p936 3100.0%
504ja5n907 3100.0%
604m219c69 3100.0%
704rs3t968 3100.0%

Download all institutions as CSV

About this data

Papers. Asclepius 2025 lists 3 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 3 of 3 papers (100.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-17 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Asclepius 2025”, https://lacuna.tiptreesystems.com/venue/asclepius/2025.

Papers

Title
AVANÇOS NO TRATAMENTO DA HIPERTENSÃO ARTERIAL: NOVAS TERAPIAS E ESTRATÉGIAS DE PREVENÇÃO
MANEJO CLÍNICO DA ASMA EM ADULTOS: TERAPIAS INOVADORAS E ABORDAGENS PERSONALIZADAS
NOVAS FRONTEIRAS NO TRATAMENTO DA DEPRESSÃO: TERAPIAS FARMACOLÓGICAS E NÃO FARMACOLÓGICAS